Navigation Links
Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
Date:5/11/2011

NASHVILLE, Tenn., May 11, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the 2011 UBS Global Specialty Pharmaceuticals Conference in London on Wednesday, May 25, 2011, at 12:30 p.m.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section of Cumberland Pharmaceuticals' website at www.cumberlandpharma.com.

Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products which improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
2. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
3. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
4. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
5. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
6. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
7. Cumberland Pharmaceuticals to Announce 2010 Financial Results on March 8, 2011
8. Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote
9. Cumberland Pharmaceuticals Announces Joey Jacobs Has Joined Its Board of Directors
10. Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
11. Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 08, 2020 , ... ... Institute of Silicon Valley, has this week announced the latest medical breakthrough for ... Molybdenum-Rhenium rod in a patient. , The newly FDA cleared MiRus Europa™ Pedicle ...
(Date:1/8/2020)... ... January 09, 2020 , ... R3 ... practices a complimentary freezer program. The cryogenic freezer allows practices to have plenty ... stem cell and exosome biologics require cryogenic freezing. This may include a practice ...
(Date:1/7/2020)... ... 2020 , ... MemoryCare.com , a comprehensive resource for ... Care Facilities in Fargo, North Dakota. The guide identifies 2 memory care communities ... to the Alzheimer’s Association , 5.6 million people age 65 and older ...
Breaking Medicine Technology:
(Date:1/8/2020)... ... January 09, 2020 , ... ... FDAnews/CenterWatch Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... data (RWD) to generate evidence and identify gaps and challenges when conducting trials? ...
(Date:1/7/2020)... Ohio (PRWEB) , ... January 07, 2020 , ... ... veterinary equipment, technology and services, today identified six trends that will significantly impact ... occur. , “Arguably, the time shared between a provider and patient is ...
(Date:1/7/2020)... ... 2020 , ... Twenty-six people, all but one who live with Young Onset ... YOPD attend the 6th World Parkinson Congress. The participants, representing 11 countries , ... all 52 weeks in 2020. The group aims to raise at least $50,000 for ...
(Date:1/7/2020)... ... January 06, 2020 , ... A December 6 article ... surgery and fewer complications including high blood pressure and premature birth before or during ... first and their second pregnancies were less likely to suffer adverse pregnancy outcomes the ...
(Date:1/5/2020)... ... January 04, 2020 , ... NJ Top Dentist, Dr. Irvin B. ... specializes in treatment for infants, children, teens and the special needs patient. The practice ... infant nursing and oral health. , Dr. Sherman and his practice will be addressing ...
Breaking Medicine News(10 mins):